Mahindra & Mahindra Financial Services Ltd (M&MFIN) Q1 FY27 Results Analysis: PAT Surges 70%, Asset Quality at Multi-Year Best
Mahindra & Mahindra Financial Services Ltd reported Q1 FY27 numbers with revenue of Rs. 4,972.12 Cr (+12.50% YoY) and PAT growth of +69.70% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 21, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 4,972.12 Cr (+12.50% YoY) |
| PAT (Q1) | Rs. 898.65 Cr (+69.70% YoY) |
| EPS (Q1) | Rs. 6.47 (+59.00% YoY) |
| Market cap | Rs. 48,620.60 Cr |
| CMP | Rs. 349.85 |
Quarter Snapshot
M&MFIN reported a strong Q1 with PAT nearly doubling (+69.7% YoY) driven by NII expansion, operating leverage, and a sharp decline in credit costs. Asset quality improved significantly with Stage-3 and PCR at multi-year best levels, while disbursements grew 21% YoY, exceeding the steady-state guidance. The only caution is AUM growth trailing the 16-18% CAGR target, but the trajectory remains on track.
Key Investment Insights
Key Positives
- Standalone PAT grew 69.7% YoY to Rs 898.65 Cr, driven by NII expansion (+19.9% YoY) and impairment decline (-13.6% YoY).
- PPOP grew 29.8% YoY to Rs 1,755.93 Cr, the strongest growth in recent quarters.
- Cost-to-income ratio improved 377 bps YoY to 35.75%, reflecting operating leverage.
- Asset quality improved: Gross Stage-3 at 3.45% (down 40 bps YoY), Net Stage-3 at 1.48% (down 43 bps), PCR at 58.08% (up 665 bps).
- Disbursements grew 21% YoY to approximately Rs 15,560 Cr, exceeding the 15%+ CAGR guidance.
- Net profit margin expanded 614 bps YoY to 18.07%.
Risk Factors
- AUM growth of 12% YoY trails the company's 16-18% CAGR target.
- Debt/equity ratio increased to 5.00x from 4.75x YoY, indicating higher leverage.
- Capital adequacy ratio declined to 18.54% from 20.62% YoY.
- Others segment (insurance, AMC) saw margin compression from 24.96% to 14.34% YoY, with segment result down 29.5%.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.